Application Deadline
February 29, 2024

Senior Bioinformatician

We are seeking an experienced Senior bioinformatician to take the lead in designing and analyzing both next-generation sequencing (NGS) and third-generation sequencing (e.g., nanopore) experiments.

In this multifaceted role, you will help advance our next pipeline of designed diagnostic products by analyzing large and complex NGS and long-read data sets, developing software tools and algorithms for automated analysis pipelines, solving technical obstacles, producing rich data visualizations and written reports, and generating new ideas in collaboration with our R&D team.

You will report to the Director of Research & Development and Chief Operating Officer and will be based at the headquarters in Bratislava, Slovakia.

Key Responsibilities

  • Design and analyze NGS and nanopore sequencing experiments.
  • Build and maintain computational pipelines on a cloud-based high-performance computing environment.
  • Analyze high-dimensional data.
  • Make data-driven decisions to advance diagnostic pipelines and refine bioinformatic analysis tools.
  • Effectively communicate results with internal and external stakeholders using rich data visualizations, oral/written reports, and scientific publications.


  • PhD in Bioinformatics, Computer Science, or related field with demonstrable experience in analyzing sequencing data (both NGS and nanopore).
  • MSc degree holders will be considered if they can demonstrate significant experience.
  • Postgraduate experience in industry is a plus.
  • Experience with Python, R, Unix command line, version control systems (Git), and standard sequencing bioinformatic tools is strongly preferred.
  • Knowledge of machine learning algorithms and their application to sequencing data is strongly preferred.
  • Proficiency with statistical inference is preferred.
  • Comprehension of basic molecular biology as it pertains to human disease, primarily in cancer and/or infectious diseases.
  • Ability to work independently as well as part of a multidisciplinary team is essential.
  • Rigorous analytical and systematic troubleshooting skills.
  • Demonstration of goal-oriented, hands-on, and innovative approach to problem solving.
  • Excellent organizational and reasoning skills are a must.
  • Excellent written and oral communication skills (English is our working language).‍

We offer

We offer a great career with development opportunities in a highly motivating and professional environment. You may be looking for a new career path or simply looking to contribute to a small, hard-working organization with the ambition to make a difference.

You will be offered the opportunity to spearhead the next ground-breaking diagnostic technologies involving RNA-based next-generation sequencing.

The job will be challenging and rewarding at the same time. You will have world-class colleagues, flexible working hours, and a negotiable salary commensurate to your qualifications (starting from €2500/ month).

Application deadline

Application deadline is November 15th. Please send the application including your CV or resume with the names of 3 references and a cover letter to

Your application will be treated in accordance with our policies for processing of personal data and the General Data Protection Regulation of the EU.

Application process

Interested candidates are invited to submit their resume, cover letter, and any supporting materials to Please include "Senior Bioinformatician Application - MultiplexDX" in the subject line.

For additional information, please contact

Peter Kilian
Ilkovičova 8
84104 Bratislava, Slovakia

About MultiplexDX

MultiplexDX is one of the most innovative biotech corporations, created to bring its revolutionary technologies to the market of personalized molecular diagnostics. The company has representation in both U.S. and European markets. The collaborators of MultiplexDX are from the world’s most prestigious scientific organizations including the National Cancer Institute, Rockefeller University, Albert Einstein University, Vanderbilt University, Cornell University, Queens University (Canada), Hebrew University of Jerusalem (Israel), and the Max Delbrück Center for Molecular Medicine (Germany).

MultiplexDX IP-based and innovative platform merges histopathology methods, biomarker quantification, visualization and gene expression with a single-cell resolution by combining MDX proprietary visual and sequencing technologies into one diagnostic test. This cross-validation approach eliminates diagnostic errors and creates 100% precise cancer profiling for each patient which allows clinicians to suggest specific, personalized cancer treatment.

Find out more about MultiplexDX on Corporate website, Facebook, LinkedIn, Twitter